Scientific Information. The Parties recognise the importance, when preparing and implementing measures aimed at protecting the environmental and social conditions that affect trade between the Parties, of taking account of scientific and technical information, and relevant international standards, guidelines or recommendations.
Scientific Information. The Parties recognise the importance, when preparing and implementing measures aimed at protecting health and safety at work or the environment which affect trade between the Parties, of taking into account scientific and technical information and relevant international standards, guidelines or recommendations, while acknowledging that, where there are threats of serious or irreversible damage, the lack of full scientific certainty should not be used as a reason for postponing protective measures [81].
Scientific Information. When preparing and implementing measures aimed at protecting the environment or labour conditions that may affect trade and investment, each Party shall take into account relevant available scientific, technical and innovation-related information, and relevant international standards, guidelines or recommendations, including the precautionary principle.
Scientific Information. During the Term, each Party will submit to the other Party for review and approval all proposed academic, scientific and medical publications and public presentations relating to Products within the Field for review in connection with preservation of patent rights and/or to determine whether any of such other Party’s Confidential Information should be modified or deleted. Written copies of such proposed publications and presentations shall be submitted to the non-publishing Party no later than [ * ] before submission for publication or presentation and the non-publishing Party shall provide its comments with respect to such publications and presentations within [ * ] of its receipt of such written copy. The publishing Party shall delay the submission for publication or presentation for a period of up to [ * ] in the event the non-publishing Party can demonstrate reasonable need for such delay, including without limitation, the preparation and filing of patent applications. By mutual agreement, this period may be further extended. In addition, upon the non-publishing Party’s request, the publishing Party shall delete from the proposed submission any Confidential Information of the non-publishing Party; provided, however, that with respect to a [ * ] or [ * ] by the [ * ] regarding [ * ] data or information, the [ * ] shall [ * ] or [ * ] to the [ * ] or [ * ] of such [ * ]. Trubion and Facet will each comply with standard academic practice regarding authorship of scientific publications and recognition of contribution of other parties in any publications relating to Products within the Field. Notwithstanding the rest of this Section 11.2, the Opt-Out Party may not publish any academic, scientific or medical publications or make any public presentations regarding the Royalty Product without the prior written consent of the Non-Opt-Out Party.
Scientific Information. In conformity with Article VIII.B of the Statute, Poland shall make available to the IAEA without charge all scientific information developed as a result of the assistance provided by the IAEA for the Project.
Scientific Information. 1) Prior to or, if not previously delivered, upon execution of this Agreement, F-DE shall deliver to SALMEDIX any and all Scientific Information generated or compiled by or on behalf of F-DE including, without limitation, communications to and from regulatory agencies (including, without limitation, registrational packages submitted by or on behalf of F-DE to such agencies), marketing strategies, manufacturing know-how, the Drug Master File and such other information and data necessary or useful for SALMEDIX to develop the Compound and Product and to manufacture, have manufactured, market, sell, import, distribute and/or promote the Product and for SALMEDIX to register the same throughout the Territory and qualify back-up manufacturer(s) for SALMEDIX’s marketing and sale of the Product (collectively “Data”). For the avoidance of doubt, Scientific Information and Data shall also include any such information and data generated by another entity which has gained rights to develop, market or commercialize the Product throughout the world from F-DE or any of its Affiliates and which would be necessary or useful for SALMEDIX to develop the Compound and Product and to manufacture, have manufactured, market, sell, import, distribute and/or promote the Product, and F-DE shall ensure that SALMEDIX has access to such Scientific Information and Data pursuant to Paragraph 2 below. For the purpose of this Agreement, any and all Scientific Information and Data disclosed by F-DE to SALMEDIX before execution of this Agreement shall be deemed to have been disclosed hereunder.
2) Data Sharing Committee: F-DE and SALMEDIX will form a Data Sharing Committee for data sharing and information exchange purposes, the members of which shall be mutually agreed upon between the parties hereto on a case-by-case basis. Through such committee, (i) F-DE will share with SALMEDIX all Scientific Information and Data generated or compiled by or on behalf of F-DE and (ii) SALMEDIX will share with F-DE Scientific Information and Data generated or compiled by or on behalf of SALMEDIX. The Data Sharing Committee will hold meetings as often as is necessary to support the development and commercialization of the Product in the Territory, provided, however, that it shall meet no less than once every year.
3) Each of SALMEDIX and F-DE agree to keep the other informed no less than once every six (6) months of all the Scientific Information which such party, its Affiliates/Associates and/or the Sublice...
Scientific Information. In conformity with Article VIII.B of the Statute, Portugal shall make available to the IAEA without charge all scientific information developed as a result of the assistance provided by the IAEA for the Project.
Scientific Information. Each Party, when preparing and implementing measures aimed at health and safety at work which may affect trade or investment between the Parties, shall take account of relevant scientific and technical information and related interna tional standards, guidelines or recommendations, if available, including the precautionary principle as enshrined in such international standards, guidelines or recommendations.
Scientific Information. 1. SCIENTIFIC INFORMATION developed by QUINODERM or FOUNTAIN and its licensees or sublicensees or offered to QUINODERM or FOUNTAIN by a third independent party will be shared with each other within one month after they have received or generated a final version. This sharing of information is subject to Article 5.
2. FOUNTAIN and QUINODERM have the right to use the above mentioned information for scientific and/or commercial purposes upon their own judgment.
3. Scientific data generated as part of a dossier to be used to apply for registration as a medical preparation or for the requirement of authorities will be designated "FOR REGISTRATION".
4. QUINODERM/FOUNTAIN will indicate in writing which studies and/or investigations are planned and that will be designated "FOR REGISTRATION". FOUNTAIN will make available the final version of these studies and/or investigations not later than one month after the information is in the final format.
5. If QUINODERM/FOUNTAIN decides that they are not interested in using the information from 11.3, the information will become subject to the secrecy provisions under this AGREEMENT.
Scientific Information. In conformity with Article VIII.B of the Statute, Chile shall make available to the Agency without charge all scientific information developed as a result of the assistance provided by the Agency for the project.
